About Pharmnxt Ekuse Private Limited
Data last updated: 18 February 2026
Pharmnxt Ekuse Private Limited is a private limited company based in Thane, Maharashtra, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 23 November 2021, the company has been in operation for over 5 years.
Registered with ROC Mumbai under CIN U29308MH2021PTC372043.
Capital: an authorised share capital of ₹3.6 Cr and a paid-up capital of ₹3.6 Cr. It is led by directors including Sachin Satish Joshi and Nandkumar Vasant Thakare.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 705 Plot – B, Lodha Supremus Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.3 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 40 employees as per the latest available data.
The company is associated with 1 brand - Pharmxnext. As per MCA filings, the company has open charges of ₹9.6 Cr and satisfied charges of ₹3.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmnxtbiotech.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address705 Plot – B, Lodha Supremus Thane, Maharashtra, India – 400607
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse Private Limited operates one associated brand: PharmXnext. These brands represent Pharmnxt Ekuse Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures single-use storage, mixing, and chromatography solutions for biologics production. | pharmnxtbiotech.com |
Competitors & Alternatives of Pharmnxt Ekuse Private Limited
Brands and companies operating in the same space as Pharmnxt Ekuse Private Limited include Cepheid, Blackrock Neurotech, Esco Lifesciences and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Developer of molecular diagnostic testing solutions | Sunnyvale, United States, United States | 1996 |
|
|
Medical devices for neurological therapies are developed. | Salt Lake City, United States, United States | 2008 |
|
|
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | Singapore, Singapore, Singapore | 1978 |
|
|
Laboratory and biopharmaceutical equipment is developed for production processes. | Gottingen, Germany, Germany | 1870 |
|
|
Provider of laboratory management system for researchers and clinicians | Milford, United States, United States | 1958 |
|
|
Diversified research instrument systems are manufactured and supplied. | United States | 1960 |
|
|
Multiplex protein stability platform for biologics is developed. | Pleasanton, United States, United States | 2015 |
|
|
Instruments for life sciences research and applications are developed. | San Francisco, United States, United States | 1999 |
|
|
Provider of products for biomedical testing for R&D, diagnostic and commercial applications | Brea, United States, United States | 1935 |
Business Activity of Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details for Pharmnxt Ekuse Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse Private Limited is audited by Mahadeokar & Yardi Chartered Accountants for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Mahadeokar & Yardi Chartered Accountants | Locked | Locked | Locked |
Complete auditor history for Pharmnxt Ekuse Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sachin Satish Joshi
Also directs:
Pharmnxt Biotech Llp
|
Director | 23 Nov 2021 | 4 Years 8 Months | Current |
|
Nandkumar Vasant Thakare
Also directs:
Pharmnxt Biotech Llp, Novelgy Ipsolutions Llp
|
Director | 23 Nov 2021 | 4 Years 8 Months | Current |
|
Ankush Kapoor
Also directs:
Pharmnxt Biotech Llp
|
Director | 23 Nov 2021 | 4 Years 8 Months | Current |
Financials of Pharmnxt Ekuse Private Limited FY 2025 filings available
Pharmnxt Ekuse Private Limited reported revenue of ₹30.3 Cr (up 408.00% YoY) for FY 2025.
Ten-year financial statements for Pharmnxt Ekuse Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Pharmnxt Ekuse Private Limited
Shareholding and ownership data for Pharmnxt Ekuse Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmnxt Ekuse Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2024 | Yes Bank Limited | ₹9.6 Cr | Open |
| 28 Aug 2023 | Others | ₹3.5 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse Private Limited has a workforce of 40 employees as of Oct 20, 2025.
Employee and EPFO history for Pharmnxt Ekuse Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Pharmnxt Ekuse Private Limited
GST registrations and filing compliance for Pharmnxt Ekuse Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Pharmnxt Ekuse Private Limited
Credit ratings, litigation, and regulatory alerts for Pharmnxt Ekuse Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmnxt Ekuse Private Limited
MSME payment history for Pharmnxt Ekuse Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmnxt Ekuse Private Limited
Corporate group structure for Pharmnxt Ekuse Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmnxt Ekuse Private Limited
MCA filings and documents for Pharmnxt Ekuse Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Pharmnxt Ekuse Private Limited
Frequently Asked Questions about Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse Private Limited is an active private limited company in the healthcare sector based in Thane, Maharashtra, India. It was incorporated on 23 November 2021 (5+ years old) and is registered under CIN U29308MH2021PTC372043. The company has 40 employees.
Pharmnxt Ekuse Private Limited reported revenue of ₹30.3 Cr for FY 2025 (up 408.00% YoY).
The current directors of Pharmnxt Ekuse Private Limited are:
- Sachin Satish Joshi - Director
- Nandkumar Vasant Thakare - Director
- Ankush Kapoor - Director
The primary industry of Pharmnxt Ekuse Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.
Pharmnxt Ekuse Private Limited can be reached at the registered office: 705 Plot – B, Lodha Supremus Thane, Maharashtra, India – 400607, or through the website pharmnxtbiotech.com.
The authorised capital is ₹3.6 Cr, and the paid-up capital is ₹3.6 Cr.